首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Primary lymphoma of the liver -- morphological and clinical analysis of 6 cases. Success of aggressive treatment.
【24h】

Primary lymphoma of the liver -- morphological and clinical analysis of 6 cases. Success of aggressive treatment.

机译:肝原发性淋巴瘤-形态和临床分析6例。积极治疗的成功。

获取原文
获取原文并翻译 | 示例
           

摘要

Histological, clinical and immunohistochemical analysis of 6 cases of primary liver lymphomas (PLL) are presented. PLL represents 4.3% of primary malignant liver tumors diagnosed in our department. The patients were relatively young people, who despite the presence of a large tumor, were in good general health status. There were no signs of scirrhosis, and cancer markers were normal. All lymphomas were CD20, CD79a, BAX positive, CD3, CD30, EMA, CD10, CD5, CD59, c-myc, Bcl2, EBV(LMP), CK negative. The proliferation index (Ki67) was high, ranging from 50-100%. In two cases positive staining for Bcl6 and in another one for cyclin D1 was obtained. The major histological type of the tumor was diffuse large B-cell lymphoma. Positive immunohistochemical results with BAX and the lack of Bcl2, c-myc and CD59 are associated with better prognosis. We have not confirmed the value of Bcl6 and CD10 stains as a predictor of poor outcome. Despite clinically advanced stage at the time of diagnosis, if treated appropriately, the primary lymphoma of the liver has relatively good prognosis (five of our patients are alive).
机译:介绍了6例原发性肝淋巴瘤(PLL)的组织学,临床和免疫组化分析。 PLL占本部门诊断出的原发性恶性肝肿瘤的4.3%。患者是相对年轻的人,尽管存在大的肿瘤,但总体健康状况良好。没有肝硬化的迹象,癌症指标正常。所有淋巴瘤均为CD20,CD79a,BAX阳性,CD3,CD30,EMA,CD10,CD5,CD59,c-myc,Bcl2,EBV(LMP),CK阴性。增殖指数(Ki67)高,介于50-100%之间。在两种情况下,获得了对Bcl6的阳性染色,在另一种情况下获得了对细胞周期蛋白D1的染色。肿瘤的主要组织学类型是弥漫性大B细胞淋巴瘤。 BAX免疫组化结果阳性和缺乏Bcl2,c-myc和CD59与更好的预后相关。我们尚未证实Bcl6和CD10染色可作为预后不良的指标。尽管在诊断时临床上处于晚期,但如果进行适当的治疗,则原发性肝淋巴瘤的预后相对较好(本病中有5名患者活着)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号